BioPharmSignal logoBioPharmSignal

Biotech News

Clover Health Reports Third Quarter 2026 Results

Clover Health (CLOV)Clover HealthEarnings

Business Highlights: Strong third quarter performance brings year-to-date GAAP Net Income to $62 million alongside 49% year-over-year Medicare Advantage membership growth Improved Full Year 2026 guidance across all metrics 2027 AEP tracking well, with significant growth due to strong product

Related news

CLOVClover Health2026-08-05 20:05 EST

Clover Health Reports Second Quarter 2026 Results

CLOVClover Health2026-05-06 20:05 EST

Clover Health Reports First Quarter 2026 Results

View all latest news

Clover Health

Medicare Advantage Clover Health operates a wide-network Medicare Advantage plan designed to improve access and outcomes for older adults, including populations that have historically lacked affordable, high-quality care. Clover Assistant Its clinical model is powered by Clover Assistant, an AI-enabled software platform that aggregates...

Recent company news

CLOVClover Health2026-11-04 21:05 EST

Clover Health Reports Third Quarter 2026 Results

CLOVClover Health2026-10-26 20:05 EST

Clover Health to Participate in Upcoming UBS Global Healthcare Conference

CLOVClover Health2026-10-19 20:30 EST

Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States

CLOVClover Health2026-10-08 22:45 EST

Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027

CLOVClover Health2026-10-07 20:05 EST

Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026

Stock data

Close
4.48 USD
Market cap
1.96B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States